Posts

Showing posts with the label Fentanyl Overdose market outlook

Fentanyl Overdose – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035

Fentanyl Overdose Market Outlook Thelansis’s “Fentanyl Overdose Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Fentanyl Overdose treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest impact on the market’s trajectory? What insig...

Fentanyl Overdose – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

  Fentanyl Overdose Market Outlook Thelansis’s “Fentanyl Overdose Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Fentanyl Overdose treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Fentanyl Overdose Overview Fentanyl, a synthetic opioid, is employed in the management of intense pain. It possesses a potency 50 to 100 times greater than that of morphine. There are two categories of fentanyl: pharmaceutical and nonpharmaceutical. Medical professionals prescribe the former, and is available in various forms like pills, lozenges, nasal or sublingual sprays, skin patches, and injections. On the other hand, nonpharmaceutical fentanyl i...

Fentanyl Overdose – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  Fentanyl, a synthetic opioid, is employed in the management of intense pain. It possesses a potency 50 to 100 times greater than that of morphine. There are two categories of fentanyl: pharmaceutical and nonpharmaceutical. Medical professionals prescribe the former, and is available in various forms like pills, lozenges, nasal or sublingual sprays, skin patches, and injections. On the other hand, nonpharmaceutical fentanyl is produced illicitly and is often mixed as a powder or liquid with illegal substances such as cocaine, methamphetamine, and heroin or used in counterfeit prescription pills. Illicit drugs known as fentanyl analogues, including acetyl fentanyl, furanyl fentanyl, carfentanil, and U-47700, share chemical structures that resemble but are not identical to fentanyl. Identifying these analogues is challenging as they necessitate specialized toxicology tests for detection. While some fentanyl analogues are less potent than fentanyl, others are significantly stronger...